Compare Dolby Laboratories, Inc. (DLB) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs Cassava Sciences Inc — how do they compare? Dolby Laboratories, Inc. trades at $60.91 (market cap $5.75B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Dolby Laboratories, Inc. is far larger — about 120.4× Cassava Sciences Inc's market cap, and Dolby Laboratories, Inc. pays a 2.35% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| DLB | FLNA | |
|---|---|---|
Market Cap | $5.75B | $47.75M |
Sector | Industrials | Health |
52-Week High | $75.62 | $4.64 |
52-Week Low | $48.51 | $0.87 |
Enterprise Value | $5.12B | -$34.93M |
Dividend Yield | 2.35% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
